|
Development of a conversation aid tool for patients with localized renal cell carcinoma at high risk of recurrence. |
|
|
Consulting or Advisory Role - Cambridge Medical Robotics; EUSA Pharma; Pfizer |
Speakers' Bureau - Pfizer |
Research Funding - Intuitive Surgical; Pfizer |
Travel, Accommodations, Expenses - Pfizer |
|
|
|
Stock and Other Ownership Interests - Pfizer |
|
|
Research Funding - Pfizer |
|
|
Research Funding - Pfizer |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Cardinal Health; Fresenius; Genentech; Hologic; Merck; Sanofi; Varian Medical Systems |
|
|
Consulting or Advisory Role - Bayer; MSD; Novartis; Pfizer |
Speakers' Bureau - Ipsen; Pfizer |
Travel, Accommodations, Expenses - Medac; Pfizer |
|
|
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Novartis; Pfizer |
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer |
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Novartis; Pfizer (Inst); Roche/Genentech (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer |